Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Open in API
Filings indexed 613 across all filing types
Latest filing 2023-09-20 Capital/Financing Update
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
Inside information: Optomed Plc successfully completes directed share issue raising EUR 4.3 million
Capital/Financing Update Classification · 98% confidence The document is an 'Inside information' announcement from Optomed Plc regarding the successful completion of a 'directed share issue' which raised EUR 4.3 million. This action involves issuing new shares to investors, which directly relates to the company's capital structure and fundraising activities. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV). Since it details the specifics of the share issuance, it is more specific than a general 'Share Issue/Capital Change' (SHA) which might cover splits or rights issues, but 'CAP' covers fundraising activities explicitly. Given the focus on raising capital via a share issue, CAP is the most appropriate classification.
2023-09-20 English
Optomedin osakkeenomistajien nimitystoimikunta
Board/Management Information Classification · 95% confidence The document is a stock exchange release (Pörssitiedote) from Optomed Oyj announcing the composition of its shareholders' nomination committee. This type of announcement regarding board-related committees and governance structure does not fit into specific financial reporting categories like 10-K or IR, nor is it a report publication announcement. It falls under general regulatory announcements regarding corporate governance and board composition, making 'RNS' the most appropriate classification.
2023-09-12 Finnish
Optomedin osakkeenomistajien nimitystoimikunta
AGM Information Classification · 99% confidence The document is a brief official announcement (Pörssitiedote) from Optomed Oyj regarding the composition of its Shareholders' Nomination Committee (osakkeenomistajien nimitystoimikunta). It details which major shareholders have appointed representatives to this committee, which is responsible for preparing proposals for the Board of Directors' composition and remuneration for the next general meeting. This type of announcement concerns corporate governance structure and the process leading up to shareholder meetings, but it is not the proxy statement (DEF 14A), the AGM presentation (AGM-R), or the results of a vote (DVA). It is a specific announcement about the governance body responsible for board nominations. This fits best under Governance Information (CGR), as it details internal rules/structure related to board composition, or potentially Regulatory Filings (RNS) as a general disclosure. Given the specific focus on the nomination committee structure, CGR is a strong fit, but since it is a very specific procedural announcement about a governance body, and not a comprehensive governance report, RNS (Regulatory Filings) serves as a safe and appropriate fallback for specific, non-standard governance updates that don't fit the other categories perfectly. However, since the committee's function is directly related to board structure and shareholder influence, CGR (Governance Information) is the most precise fit among the options provided for this type of corporate governance update.
2023-09-12 Finnish
Composition of Optomed's Nomination Board
Governance Information Classification · 95% confidence The document is a 'Stock Exchange Release' from Optomed Plc dated September 12, 2023, announcing the 'Composition of Optomed's Nomination Board'. It details which shareholders are represented and who they have appointed to the board. The Nomination Board's function is explicitly stated: 'to prepare proposals on the composition and members of the Board of Directors and their remuneration for the next Annual General Meeting'. This content directly relates to the governance structure, board composition, and preparation for shareholder meetings, which falls under Governance Information (CGR) or potentially Board/Management Information (MANG). Since it specifically details the structure and function of the Nomination Board responsible for proposing board members and remuneration for the AGM, it aligns most closely with Governance Information (CGR), which covers internal rules and board structure, or potentially DEF 14A if it were focused purely on remuneration proposals, but CGR is broader for board structure. Given the options, CGR (Governance Information) is the best fit as it concerns the structure and process related to the Board of Directors' composition and future AGM proposals, rather than just management changes (MANG) or remuneration details (DEF 14A). It is a formal announcement of governance structure setup.
2023-09-12 English
Optomed Plc - Managers' transactions - Tauriainen
Director's Dealing Classification · 100% confidence The document is titled 'Managers' transactions' and provides specific details regarding a share-based incentive received by a member of the Board (Reijo Tauriainen). It includes the issuer name, transaction date, instrument type, and volume, which are standard components of a Director's Dealing report. This fits the definition of 'DIRS' (Director's Dealing) perfectly.
2023-08-07 English
Optomed Plc - Managers' transactions - Tenstam
Director's Dealing Classification · 100% confidence The document is titled 'Managers' transactions' and details a specific share-based incentive receipt by a member of the Board (Anna Tenstam). This aligns perfectly with the definition of a Director's Dealing (DIRS) report, which tracks personal share transactions by company directors and executives.
2023-08-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.